Pictet Asset Management Holding SA Increases Holdings in The Cooper Companies, Inc. (NASDAQ:COO)

Pictet Asset Management Holding SA raised its stake in shares of The Cooper Companies, Inc. (NASDAQ:COO - Free Report) by 7.1% in the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 145,085 shares of the medical device company's stock after purchasing an additional 9,650 shares during the quarter. Pictet Asset Management Holding SA owned 0.07% of Cooper Companies worth $13,338,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

A number of other hedge funds and other institutional investors have also bought and sold shares of COO. Byrne Asset Management LLC bought a new position in shares of Cooper Companies during the 4th quarter valued at about $33,000. OFI Invest Asset Management purchased a new stake in Cooper Companies in the fourth quarter worth approximately $34,000. New Age Alpha Advisors LLC bought a new position in Cooper Companies during the fourth quarter valued at approximately $38,000. West Financial Advisors LLC purchased a new position in shares of Cooper Companies during the fourth quarter worth approximately $49,000. Finally, Atala Financial Inc purchased a new position in shares of Cooper Companies during the fourth quarter worth approximately $51,000. Hedge funds and other institutional investors own 24.39% of the company's stock.

Analyst Ratings Changes

Several research analysts have recently commented on COO shares. Piper Sandler reiterated an "overweight" rating and issued a $115.00 price objective (down previously from $120.00) on shares of Cooper Companies in a report on Friday, March 7th. Robert W. Baird lowered their price objective on Cooper Companies from $117.00 to $107.00 and set an "outperform" rating for the company in a research report on Friday, March 7th. Needham & Company LLC restated a "hold" rating on shares of Cooper Companies in a report on Friday, March 7th. Stifel Nicolaus lowered their price target on shares of Cooper Companies from $115.00 to $105.00 and set a "buy" rating for the company in a report on Friday, March 7th. Finally, JPMorgan Chase & Co. dropped their price target on shares of Cooper Companies from $120.00 to $110.00 and set an "overweight" rating for the company in a research report on Friday, March 7th. Four analysts have rated the stock with a hold rating and seven have issued a buy rating to the stock. Based on data from MarketBeat.com, the company currently has a consensus rating of "Moderate Buy" and a consensus target price of $110.25.

Remove Ads

Cooper Companies Trading Down 5.6 %

Shares of NASDAQ:COO traded down $4.40 on Friday, hitting $73.77. The company had a trading volume of 2,661,526 shares, compared to its average volume of 1,367,710. The Cooper Companies, Inc. has a 1 year low of $73.34 and a 1 year high of $112.38. The company has a quick ratio of 1.12, a current ratio of 1.91 and a debt-to-equity ratio of 0.32. The firm's 50-day simple moving average is $87.76 and its two-hundred day simple moving average is $96.14. The firm has a market capitalization of $14.75 billion, a price-to-earnings ratio of 37.83, a P/E/G ratio of 2.25 and a beta of 1.01.

Cooper Companies (NASDAQ:COO - Get Free Report) last posted its earnings results on Thursday, March 6th. The medical device company reported $0.92 earnings per share for the quarter, hitting analysts' consensus estimates of $0.92. The firm had revenue of $964.70 million for the quarter, compared to the consensus estimate of $981.25 million. Cooper Companies had a return on equity of 9.38% and a net margin of 10.07%. Equities analysts anticipate that The Cooper Companies, Inc. will post 3.98 earnings per share for the current fiscal year.

Cooper Companies Profile

The Cooper Companies, Inc, together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical. The CooperVision segment provides spherical lense, including lenses that correct near and farsightedness; and toric and multifocal lenses comprising lenses correcting vision challenges, such as astigmatism, presbyopia, and myopia in the Americas, Europe, Middle East, Africa, and Asia Pacific.